3D 세포배양 시장 규모는 2022년에 18억 8,000만 달러로 평가되며, 2023-2030년 CAGR은 10.87%로, 2030년에는 43억 달러에 달할 것으로 예측됩니다. 이 부문의 기술 발전, 동물 실험의 대안 개발에 대한 관심 증가, 만성질환의 유병률 증가, 신제품 출시는 예측 기간 중 3D 세포배양 시장을 촉진할 것으로 예상되며, 세계의 3D 세포배양 시장 보고서는 이 시장에 대한 종합적인 평가를 제공합니다. 주요 부문, 동향, 시장 성장 촉진요인, 경쟁 환경, 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석합니다.
세계 3D 세포배양 시장의 정의
3D 세포배양은 인위적으로 만들어진 환경으로, 3D 세포배양 환경은 생물학적 세포가 주변 환경과 3차원적으로 상호 작용할 수 있도록 합니다. 세포의 특성과 거동에서 3D 세포배양으로 배양된 세포는 생체 내에서 발견되는 세포와 유사한 특성을 나타내며, in vivo 조건에서 이 기술은 세포를 자연 환경에서 증식시킬 수 있습니다. 세포를 인공적으로 만들어진 환경에서 성장시킬 수 있습니다.
생물학적 세포는 이 환경에서 3차원적으로 자유롭게 성장하고 주변 환경과 상호 작용할 수 있습니다. 바이오리액터나 소형 캡슐은 이러한 3차원 환경에서 세포를 증식시키기 위해 자주 사용됩니다. 3차원 세포배양은 3차원 주변 환경에 반응하여 일반 세포에서 분화 및 유주합니다. 세포의 유용성이 증가하여 조직의 성숙과 조직화를 돕습니다. 이 방법은 제약 회사, 생명 공학 기업, 학술기관 및 연구소에서 일반적으로 사용됩니다.
3D 배양은 장기의 정상적인 형태와 미세구조를 정확하게 재현할 수 있으므로 생체내 모델 시스템을 필요로 하는 연구에서 신체 조직이나 장기에 대한 이물질의 영향을 조사하는 데 자주 사용됩니다. 또한 3차원 장기형 구조를 제작하는 데 사용되는 생체 모방 조직 구축으로 인해 많은 연구기관에서 3D 세포배양 기술을 채택하고 있습니다. 또한 COVID-19, 암 및 기타 임상 질환을 치료하기 위한 기존 방식에 대한 새로운 접근법으로 3D 조직 공학 모델의 활용이 등장하고 있습니다.
세계 3D 세포배양 시장 개요
폐암, 피부암과 같은 종양성 질환에 대한 일반 대중의 인식이 높아지고, 3D 세포배양의 높은 강도와 저렴한 가격 등 3D 세포배양의 매력적인 장점은 3D 세포배양 시장의 확대를 촉진할 것으로 예상되는 요인 중 하나입니다. 또한 의약품 개발에서 3D 세포배양 활용이 증가하고 암 연구 및 첨단 기술, 신제품 출시에 대한 정부의 적극적인 재정적 지원도 3D 세포배양 시장을 촉진할 것으로 예상됩니다. 또한 동물실험을 대체할 수 있는 대체법 개발에 대한 중요성이 강조되고 시장 인지도가 높아지는 것도 시장을 촉진할 것으로 예상됩니다. 만성질환의 유병률 증가와 연구를 위한 자금 조달이 가능해짐에 따라 예측 기간 중 시장 성장을 가속할 것으로 예상됩니다.
또한 신약 개발, 기술 혁신, 스크리닝을 위한 R&D 노력과 암 연구에서 3D 세포배양 사용에 대한 선호도가 시장 성장을 가속할 것으로 예상됩니다. 마찬가지로 장기 이식 수요 증가는 3D 세포배양 시장의 성장을 가속할 것으로 예상됩니다. 저성장 인자 기반에서 배양된 세포는 인간에게 이식할 수 없습니다. 따라서 천연 ECM의 기능성과 생물학적 및 재료적 특성을 지정할 수 있는 능력을 모두 제공하는 재료의 필요성이 강조되고 있습니다. 이러한 합성 펩티드를 포함한 합성 물질로 만든 스캐폴더는 이러한 장애를 해결할 것으로 기대되지만, 일관성 부족은 시작되기까지 시장의 큰 문제로 남아 있습니다.
또한 과도한 기술 비용과 숙련된 전문가 부족도 시장 성장에 걸림돌이 될 것으로 예상됩니다. 또한 COVID-19 팬데믹으로 인해 3D 세포배양은 3D 세포배양 컴포넌트 수요와 가용성의 균형을 맞추는 데 있으며, 심각한 새로운 어려움에 직면해 있습니다. 신경근 질환의 첨단 치료 및 진단과 같은 발명 증가는 분석 기간 중 세계 3D 세포배양 시장에 풍부한 성장 기회를 제공할 것으로 예상됩니다. 또한 전체 척수 운동 회로를 재현하기 위한 3D 세포배양의 발전은 시장을 성장시킬 것으로 예상되며, COVID-19에 대한 새로운 치료법을 개발하기 위한 과학적 연구 증가는 시장 성장의 큰 기회를 보여주고 있습니다.
시장의 매력
제공된 시장 매력의 이미지는 세계 3D 세포배양 시장에서 주로 선도하는 지역에 대한 정보를 얻는 데 도움이 됩니다. 우리는 지정된 지역의 산업 성장을 가속하는 주요 영향요인을 다루고 있습니다.
Porter's Five Forces
이 이미지는 경쟁사의 행동과 각 산업에서 기업의 전략적 포지셔닝을 이해하기 위한 청사진을 제공하는 Porter의 Five Forces 프레임워크에 대한 정보를 얻는 데 도움이 될 것입니다. Porter의 Five Forces 모델은 세계 3D 세포배양 시장 경쟁 구도를 평가하고, 특정 분야의 매력을 측정하고, 투자 잠재력을 평가하는 데 사용할 수 있습니다.
3D Cell Culture Market size was valued at USD 1.88 Billion in 2022 and is projected to reach USD 4.30 Billion in 2030 , at a CAGR of 10.87% from 2023 to 2030. Technological advancements in this segment, a growing emphasis on developing alternatives to animal testing, rising incidences of chronic diseases, and new product launches are expected to drive the 3D Cell Culture Market over the forecast years. The Global 3D Cell Culture Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global 3D Cell Culture Market Definition
3D cell culture is an artificially-created environment. A three-dimensional cell culture environment allows biological cells to interact with their surroundings in all three dimensions. In terms of cellular characteristics and behavior, cells grown in 3D cell culture exhibit similar properties to cells found in living organisms. In an in vivo condition, this technique allows cells to grow in their natural environment. In contrast to 2D environments, 3D cell culture enables cells to grow in all directions in an artificially created environment.
Biological cells are free to grow and interact with their surroundings in all three dimensions in this environment. Bioreactors and small capsules are frequently used to grow these three-dimensional environments in which cells can grow. 3D cell culture differentiates and migrates from normal cells by reacting to their three-dimensional surroundings. The enhanced utility of the cell aids in tissue maturation and organization. This method is commonly used in pharmaceutical and biotechnology companies, as well as academic institutions and research labs.
3D cultures are commonly used during research that requires in vivo model systems to study the effects of a foreign substance on bodily tissues and organs because they can precisely recreate the normal morphology and microarchitecture of organs. Moreover, due to the biomimetic tissue constructions used to produce 3D organotypic structures, a substantial number of research entities adopted 3-dimensional cell culture techniques. Furthermore, a novel approach to conventional methods for treating Covid-19, cancer, and other clinical illnesses has emerged: the use of 3D tissue-engineered models.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global 3D Cell Culture Market Overview
Rising public awareness of oncological diseases such as lung cancer and skin cancer, as well as the appealing benefits of 3D cell culture such as high strength and low prices, are among the factors expected to propel the expansion of the 3D Cell Culture Market. Moreover, its rising use in drug development and active government financial support for cancer research and advanced technologies as well as new product launches are anticipated to propel the 3D Cell Culture Market. In addition, the growing emphasis on developing alternatives to animal testing and growing market awareness is anticipated to drive the market. The availability of funding for research as well as the increasing incidence of chronic illnesses is predicted to fuel the market growth during the forecast years.
Furthermore, R&D efforts for drug discovery, innovation, and screening, as well as a preference for the use of 3D Cell culture in cancer research, are expected to propel market growth. Similarly, an increase in demand for organ transplantation is projected to augment the 3D Cell Culture Market growth. Cells grown on low-growth-factor scaffolds cannot be implanted in humans. This emphasises the need for materials that provide both natural ECM functionality and the ability to specify biological and material properties. Scaffolds made of synthetic materials, including such synthetic peptides, are anticipated to address this hindrance, however, lack of consistency continues to be a significant market problem until their initiation.
Moreover, excessive technology costs and a scarcity of skilled professionals are also anticipated to hamper market growth. Furthermore, Due to the COVID-19 pandemic, 3D cell culture is facing serious new difficulties in balancing the demand and availability of 3D cell culture components. Increasing inventions such as advanced treatments and diagnoses in neuromuscular disease are anticipated to provide abundant growth opportunities for the global 3D Cell Culture Market during the analysis timeframe. Moreover, advancements in 3D cell culture for replicating the entire spinal locomotion circuit are expected to grow the market. The rise in scientific research for developing novel therapies against COVID-19 represents a significant opportunity for market growth.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global 3D Cell Culture Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter's Five Forces
The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global 3D Cell Culture Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
The Global 3D Cell Culture Market is segmented on the basis of Type, Application, End Users, And Geography.
Based on Type, the market is segmented into 3D Bioreactors, Scaffold-Based Platform, Scaffold-Free Platform, and Other. 3D Bioreactors accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 20.03% during the forecast period. The bioreactor is composed of many independent, autoclavable polycarbonate chambers. The chambers are interchangeable and have been particularly designed to take advantage of 3D Insert scaffolds in sizes ranging from 24-well to 12-well to 6-well. Cell culture media is perfused through the open porous structure of scaffolds using a peristaltic pump. The entire unit is autoclavable and can be utilized as a single-use bioreactor system. Scaffold-based 3D Cell Cultures was the second-largest market in 2021, projected to grow at the highest CAGR of 18.88%.
Based on Application, the market is segmented into Stem Cell Research, Cancer Research, Drug Discovery, and Regenerative Medicine. Stem cell research accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.40% during the forecast period. Merck is driven to develop novel cell culture systems and characterization tools for stem cell research and primary cell culture. Merck provides a complete line of stem cell products, such as human and murine stem cells, stem cell and primary cell culture media, growth factors, exclusive antibodies, culture ware, and kits. Cancer Research was the second-largest market in 2021, projected to grow at the highest CAGR of 18.90%.
Based on End Users, the market is segmented into Academic Institutes, Contract Research Laboratories & Diagnostics Centers, and Biotechnology and Pharmaceutical Companies. Contract Research Laboratories & Diagnostics Center accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.24% during the forecast period. These contract research laboratories assist the primary R&D activities, by minimizing the time and resources required to complete the research project.
3D cell culture is the fastest growing segment in the healthcare space due to a wide range of applications in cancer research, in vitro environment, and regenerative medicine. The rise in the adoption of 3D cell culture in diagnostic centers and an increase in demand for organ transplantation and tissue regeneration leads to an increase in the growth of the segment. Biotechnology & Pharmaceutical Companies was the second-largest market in 2021, projected to grow at the highest CAGR of 18.76%.
Based on Geography, the Global 3D Cell Culture Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Middle East and Africa accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 22.66% during the forecast period. The steadily growing pharmaceutical industry and rising chronic diseases in the region are factors that lead to the increasing adoption of 3D cell culture, as cell culture is a vital function for drug discovery and cancer research which, in turn, helps to push the market growth over the forecast period.
Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players globally.